In glioblastoma, tumor cells can secrete chemokines such as C-C motif chemokine ligand 22 (CCL22), which binds to the C-C chemokine receptor type 4 (CCR4) receptor on the surface of Tregs, thereby recruiting Tregs and enhancing immunosuppression [53]. This evidence concerns the gene CCR4 and neoplasm.